γδ T-PD-1 Ab Cells therapy(Changzhou No.2 People’S Hospital)

N/A

Report date: 2024/08/23 20:00:42

Base Information

Drug Nameγδ T-PD-1 Ab Cells therapy(Changzhou No.2 People’S Hospital)
Drug Alias NameAnti-PD-1 Antibody Armored γδ T Cells therapy(Changzhou No.2 People’S Hospital)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacementsAnti-PD-1
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumoursMeningioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChangzhou No.2 People’S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou No.2 People’S HospitalNanjing Medical University
Inactive CompaniesN/A
Active IndicationsSolid tumoursMeningioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A